HBIO

Harvard Bioscience, Inc. manufactures and sells specialized laboratory equipment, tools, and technologies for life science research and drug development. Headquartered in Holliston, Massachusetts, the company operates through two primary segments: Cell and Molecular Research Products and Precision Instruments. Its product portfolio includes syringe pumps, bioreactors, cell culture systems, fluid handling equipment, and molecular biology tools used by researchers in pharmaceutical companies, biotechnology firms, government laboratories, and academic institutions worldwide. The company serves customers across North America, Europe, and Asia through direct sales forces and distribution partners. Harvard Bioscience has grown significantly through strategic acquisitions, having integrated multiple complementary businesses over the past two decades to expand its product offerings and market reach. The company employs approximately 400 people globally and operates manufacturing and distribution facilities in the United States and Europe. Recent strategic initiatives focus on advancing cell therapy research tools and expanding its regenerative medicine product line, particularly through its MIVO product for organ preservation and its bioreactor systems for cell expansion. With annual revenues in the range of $100-120 million, Harvard Bioscience positions itself as a specialized provider serving niche segments within the broader life sciences tools and equipment market, competing alongside both larger diversified laboratory suppliers and smaller specialized manufacturers.